PharmaShots | Incisive News in 3 Shots

Subscribe Now

Positive Opinion

Amgen's Lumykras (sotorasib) Receives CHMP's Positive Opinion for the Treatment of KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer

Amgen's Lumykras (sotorasib) Receives CHMP's Positive Opinion for the Treatment of KRAS G12C-Mutated Advanced Non-Small Cell Lung...

November 15, 2021

Celltrion's CT-P59 (regdanvimab) Receives CHMP's Positive Opinion for the Treatment of COVID-19

Celltrion's CT-P59 (regdanvimab) Receives CHMP's Positive Opinion for the Treatment of COVID-19

November 12, 2021

AbbVie-Skyrizi (risankizumab) Receives CHMP's Positive Opinion for the Treatment of Adults with Active Psoriatic Arthritis in the EU

AbbVie-Skyrizi (risankizumab) Receives CHMP's Positive Opinion for the Treatment of Adults with Active Psoriatic Arthritis in the...

October 18, 2021

Bristol Myers Squibb's Zeposia (ozanimod) Receives CHMP's Positive Opinion for Adult Patients with Moderately to Severely Active Ulcerative Colitis

Bristol Myers Squibb's Zeposia (ozanimod) Receives CHMP's Positive Opinion for Adult Patients with Moderately to Severely Active U...

October 15, 2021

Sanofi's Avalglucosidase alfa Receives CHMP's Positive Opinion for Patients with Pompe Disease

Sanofi's Avalglucosidase alfa Receives CHMP's Positive Opinion for Patients with Pompe Disease

July 28, 2021

Alexion's Ultomiris (ravulizumab) Receives CHMP's Positive Opinion Recommending its Approval for Children and Adolescents with PNH

Alexion's Ultomiris (ravulizumab) Receives CHMP's Positive Opinion Recommending its Approval for Children and Adolescents with PNH

July 26, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us